» Articles » PMID: 21514265

Recovering Circulating Extracellular or Cell-free RNA from Bodily Fluids

Overview
Publisher Elsevier
Specialties Oncology
Public Health
Date 2011 Apr 26
PMID 21514265
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

The presence of extracellular circulating or cell-free RNA in biological fluids is becoming a promising diagnostic tool for non invasive and cost effective cancer detection. Extracellular RNA or miRNA as biological marker could be used either for the early detection and diagnosis of the disease or as a marker of recurrence patterns and surveillance. In this review article, we refer to the origin of the circulating extracellular RNA, we summarise the data on the biological fluids (serum/plasma, saliva, urine, cerebrospinal fluid and bronchial lavage fluid) of patients suffering from various types of malignancies reported to contain a substantial amount of circulating extracellular (or cell-free) RNAs and we discuss the appropriate reagents and methodologies needed to be employed in order to obtain RNA material of high quality and integrity for the majority of the experimental methods used in RNA expression analysis. Furthermore, we discuss the advantages and disadvantages of the RT-PCR or microarray methodology which are the methods more often employed in procedures of extracellular RNA analysis.

Citing Articles

Extracellular vesicles, RNA sequencing, and bioinformatic analyses: Challenges, solutions, and recommendations.

Miceli R, Chen T, Nose Y, Tichkule S, Brown B, Fullard J J Extracell Vesicles. 2024; 13(12):e70005.

PMID: 39625409 PMC: 11613500. DOI: 10.1002/jev2.70005.


TMEM158, as plasma cfRNA marker, promotes proliferation and doxorubicin resistance in ovarian cancer.

Zhu X, Liu T, Yin X Pharmacogenomics J. 2024; 24(6):34.

PMID: 39543089 DOI: 10.1038/s41397-024-00357-8.


Plasma acellular transcriptome contains Parkinson's disease signatures that can inform clinical diagnosis.

Beric A, Cisterna-Garcia A, Martin C, Kumar R, Alfradique-Dunham I, Boyer K medRxiv. 2024; .

PMID: 39484251 PMC: 11527085. DOI: 10.1101/2024.10.18.24315717.


Oncogenic microRNA-1290 and Gene as Potential Biomarker for Colorectal Carcinoma.

Naseem R, Shahid S, Shahid W, Abbas G Technol Cancer Res Treat. 2024; 23:15330338241286283.

PMID: 39327992 PMC: 11439174. DOI: 10.1177/15330338241286283.


Liquid biopsy: paving a new avenue for cancer research.

Kurma K, Eslami-S Z, Alix-Panabieres C, Cayrefourcq L Cell Adh Migr. 2024; 18(1):1-26.

PMID: 39219215 PMC: 11370957. DOI: 10.1080/19336918.2024.2395807.